Search Results - "Griep, Ed"

High prevalence of hip involvement and decrease in inflammatory ultrasound lesions during tumour necrosis factor-α blocking therapy in ankylosing spondylitis by Wink, Freke, Arends, Suzanne, Maas, Fiona, Bootsma, Hendrika, Griep, Ed N, Bruyn, George A W, Spoorenberg, Anneke

“…To assess the prevalence of clinical, US and radiographic hip involvement in AS patients with active disease and to explore the associations between these…”
Get full text

Reduced Occurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis Treated with Golimumab - The GO-EASY Study by van Bentum, Rianne E, Heslinga, Sjoerd C, Nurmohamed, Michael T, Gerards, Andreas H, Griep, Ed N, Koehorst, Charlotte B J M, Kok, Marc R, Schilder, Anna M, Verhoef, Marijn, van der Horst-Bruinsma, Irene E

“…Acute anterior uveitis (AAU) is common in ankylosing spondylitis (AS). Golimumab (GOL), a tumor necrosis factor-α inhibitor (TNFi), has proven to be effective…”
Get full text

Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial by van Boheemen, Laurette, Turk, Samina, Beers-Tas, Marian van, Bos, Wouter, Marsman, Diane, Griep, Ed N, Starmans-Kool, Mirian, Popa, Calin D, van Sijl, Alper, Boers, Maarten, Nurmohamed, Michael T, van Schaardenburg, Dirkjan

“…ObjectivesPersons at high risk of rheumatoid arthritis (RA) might benefit from a low-risk pharmacological intervention aimed at primary prevention. Previous…”
Get full text

Ultrasound Evaluation of the Entheses in Daily Clinical Practice during Tumor Necrosis Factor-α Blocking Therapy in Patients with Ankylosing Spondylitis by Wink, Fréke, Bruyn, George A, Maas, Fiona, Griep, Ed N, van der Veer, Eveline, Bootsma, Hendrika, Brouwer, Elisabeth, Arends, Suzanne, Spoorenberg, Anneke

“…To assess structural and inflammatory ultrasound (US) lesions of entheses in ankylosing spondylitis (AS) patients with active disease and to evaluate…”
Get full text

Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project by van den Oever, Inge A M, Heslinga, Maaike, Griep, Ed N, Griep-Wentink, Hanneke R M, Schotsman, Rob, Cambach, Walter, Dijkmans, Ben A C, Smulders, Yvo M, Lems, Willem F, Boers, Maarten, Voskuyl, Alexandre E, Peters, Mike J L, van Schaardenburg, Dirkjan, Nurmohamed, Micheal T

“…To assess the 10-year cardiovascular (CV) risk score and to identify treatment and undertreatment of CV risk factors in patients with established RA…”
Get full text

Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate by Verhoeven, Maxime M A, Tekstra, Janneke, Welsing, Paco M J, Pethö-Schramm, Attila, Borm, Michelle E A, Bruyn, George A W, Bos, Reinhard, Griep, Ed N, Klaasen, Ruth, van Laar, Jacob M, Lafeber, Floris P J G, Bijlsma, Johannes W J, de Hair, Marjolein J H, Jacobs, Johannes W G

“…Abstract Objectives U-Act-Early was a 2-year, randomized placebo controlled, double-blind trial, in which DMARD-naïve early RA patients were treated to the…”
Get full text

Can health care providers recognise a fibromyalgia personality? by Da Silva, José A P, Jacobs, Johannes W G, Branco, Jaime C, Canaipa, Rita, Gaspar, M Filomena, Griep, Ed N, van Helmond, Toon, Oliveira, Paula J, Zijlstra, Theo J, Geenen, Rinie

“…To determine if experienced health care providers (HCPs) can recognise patients with fibromyalgia (FM) based on a limited set of personality items, exploring…”
Get full text

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial by Mease, Philip J, Smolen, Josef S, Behrens, Frank, Nash, Peter, Liu Leage, Soyi, Li, Lingnan, Tahir, Hasan, Gooderham, Melinda, Krishnan, Eswar, Liu-Seifert, Hong, Emery, Paul, Pillai, Sreekumar G, Helliwell, Philip S

“…To compare efficacy and safety of ixekizumab (IXE) to adalimumab (ADA) in biological disease-modifying antirheumatic drug-naïve patients with both active…”
Get more information

Is radiation synovectomy for arthritis of the knee more effective than intraarticular treatment with glucocorticoids? Results of an eighteen‐month, randomized, double‐blind, placebo‐controlled, crossover trial by Jahangier, Zalima N., Jacobs, Johannes W. G., Lafeber, Floris P. J. G., Moolenburgh, Jan D., Swen, Wijnand A. A., Bruyn, George A. W., Griep, Ed N., ter Borg, Evert‐J., Bijlsma, Johannes W. J.

“…Objective To compare the clinical efficacy and safety of radiation synovectomy (RSO) with intraarticular (IA) yttrium‐90 plus glucocorticoids (GCs) with the…”
Get full text

Rheumatologists' performance in daily practice by Gorter, Simone, van der Linden, Sjef, Brauer, Jolanda, van der Heijde, Désirée, Houben, Harry, Rethans, Jan‐Joost, Scherpbier, Albert, van der Vleuten, Cees, Boonen, Annelies, Dinant, Huib, Thè, Henk Goei, Griep, Ed, van der Horst‐Bruinsma, Irene, Linssen, Annelies, van Santen‐Hoeufft, Marijke, van der Tempel, Hille, Westgeest, Toon

“…Objective To assess rheumatologists' performance for 8 rheumatologic conditions and to explore possible explanatory factors. Methods After written informed…”
Get full text

Rheumatologists' performance in daily practice by GORTER, Simone, VAN DER LINDEN, Sjef, THE, Henk Goei, GRIEP, Ed, VAN DER HORST-BRUINSMA, Irene, LINSSEN, Annelies, VAN SANTEN-HOEUFFT, Marijke, VAN DER TEMPEL, Hille, WESTGEEST, Toon, BRAUER, Jolanda, VAN DER HEIJDE, Désirée, HOUBEN, Harry, RETHANS, Jan-Joost, SCHERPBIER, Albert, VAN DER VLEUTEN, Cees, BOONEN, Annelies, DINANT, Huib

Get full text